Large owner Sanderling Venture Partners Vi Co Investment Fund Lp bought $329,040 worth of shares (87,744 units at $3.75), increasing direct ownership by 12% to 814,300 units (SEC Form 4)

11/5/24 3:08:23 PM ET

$CALC

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $CALC alert in real time by email

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sanderling Venture Partners VI Co Investment Fund LP

(Last)

(First)

(Middle)

1300 S EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [ CALC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/01/2024		P		86,867	A	$3.75	814,300	D
Common Stock	11/01/2024		P		877	A	$3.75	22,479	I	By Sanderling Ventures Management VI
Common Stock								946,744	I	By Sanderling Venture Partners VI, LP
Common Stock								7,456	I	By Sanderling VI Beteligungs GmbH & Co KG
Common Stock								8,884	I	By Sanderling VI Limited Partnership
Common Stock								435,148	I	By Sanderling Ventures VII, L.P.
Common Stock								114,260	I	By Sanderling Ventures VII (Canada), L.P.
Common Stock								27,609	I	By Sanderling Ventures VII Annex Fund, L.P.
Common Stock								30,292	I	By Sanderling Ventures Management VII

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

Sanderling Venture Partners VI Co Investment Fund LP

(Last)

(First)

(Middle)

1300 S EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling Ventures Management VI

(Last)

(First)

(Middle)

1300 S EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling VI Beteiligungs GmbH & Co KG

(Last)

(First)

(Middle)

1300 S EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling Venture Partners VI LP

(Last)

(First)

(Middle)

1300 S. EL CAMINO REAL SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling VI Limited Partnership

(Last)

(First)

(Middle)

1300 S EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling Ventures VII, L.P.

(Last)

(First)

(Middle)

1300 S. EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling Ventures VII (Canada), L.P.

(Last)

(First)

(Middle)

1300 S. EL CAMINO REAL SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling Ventures VII Annex Fund, L.P.

(Last)

(First)

(Middle)

1300 S EL CAMINO REAL

SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Sanderling Ventures Management VII

(Last)

(First)

(Middle)

1300 S. EL CAMINO REAL SUITE 203

(Street)

SAN MATEO

94402

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

	Sanderling Venture Partners VI Co-Investment Fund, L.P., By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its General Partner	11/05/2024
	Sanderling Ventures Management VI, By: /s/ Fred Middleton, Owner	11/05/2024
	Sanderling VI Beteiligungs GmbH & Co. KG, By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its Managing Limited Partner	11/05/2024
	Sanderling Venture Partners VI , L.P., By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, L.P., its General Partner	11/05/2024
	Sanderling VI Limited Partnership, By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its Investment General Partner	11/05/2024
	Sanderling Ventures VII, L.P. , By: /s/ Fred Middleton, Managing Director of M4 Partners VII, LLC, its General Partner	11/05/2024
	Sanderling Ventures VII Annex Fund, L.P., By: /s/ Fred Middleton, Managing Director of M4 Partners VII Annex, LLC, its General Partner	11/05/2024
	Sanderling Ventures VII (Canada), L.P., By: /s/ D. Michael Dixon, President of Sanderling Ventures VII (Canada) GP Inc., General Partner of Sanderling Ventures VII (Canada) G.P., L.P, its General Partner	11/05/2024
	Sanderling Ventures Management VII, By: /s/ Fred Middleton, Owner	11/05/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $CALC alert in real time by email

Large owner Sanderling Venture Partners Vi Co Investment Fund Lp bought $329,040 worth of shares (87,744 units at $3.75), increasing direct ownership by 12% to 814,300 units (SEC Form 4)

Chat with this insight

Recent Analyst Ratings for $CALC

$CALC Press Releases

Fastest customizable press release news feed in the world

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

CalciMedica Announces Pricing of Public Offering of Common Stock

CalciMedica Announces Proposed Public Offering of Common Stock

$CALC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Amendment: CHIEF BUSINESS OFFICER Roberts Eric W bought $8,040 worth of shares (3,000 units at $2.68) (SEC Form 4)